MiR-200c strongly suppressed mammary duct formation from normal mammary stem cells and tumor formation from breast cancer stem cells in vivo by targeting B lymphoma Mo-MLV insertion region 1 homolog, a regulator of stem cell self-renewal [48]. The gene discussed is BMI1; the disease is neoplasm.